StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Hologic (HOLX) Is A Best Idea for 2018 at Goldman Sachs
December 27, 2017 7:42 AM
Goldman Sachs maintains Conviction Buy on Hologic (NASDAQ: HOLX) price target of $50.00ANalyst Issac Ro believes the company remains well-positioned ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments